Intract Pharma
Transforming Patient Care by Replacing Injections with Safer, More Effective Therapeutics Given Orally.
14 employees · est. 2016 · London, United Kingdom
Ligandal
Ligandal is developing precision molecular therapeutics and targeted delivery technologies.
12 employees · est. 2014 · San Francisco, United States
Ligandal is the older company (2016 vs 2014).
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Intract Pharma | Ligandal |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2014 older |
| Headquarters | ||
| Headquarters | London, United Kingdom | San Francisco, United States |
| Employees | ||
| Employees | 14 | 12 |
| Industry | ||
| Industry | Biotechnology, Life Sciences, Pharmaceutical | Biotechnology |
| Funding Stage | ||
| Funding Stage | Seed | Seed |
| Total Funding | ||
| Total Funding | $420.00K | $2.13M |
| Funding Rounds | ||
| Funding Rounds | 3 | 3 |
| Services | ||
| Services | Development of oral drug delivery systems, Biotech drug formulations, Collaborative biopharmaceutical research and development, Preclinical research and trials | Not tracked yet |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Healthcare providers, Patients requiring biologic therapies, Biotech organizations | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Oral Drug Delivery, Biotechnology Innovation, Monoclonal Antibodies, Gastrointestinal Treatment, Immune-mediated Inflammatory Diseases, Phloral™ Technology, Soteria™ Technology, Protein Delivery, Systemic Immunomodulation, Colon Targeted Delivery, Injectable To Oral Conversion, Biologic Medicines, Proprietary Formulation Technologies, University Spin-out, Pharmaceutical Research And Development | Precision Medicine, Genetic Medicine, Nanotechnology, Therapeutics, Vaccines, Immuno-oncology, Rare Genetic Diseases, Peptide-based Cure, COVID-19, Nanomedicine, Gene Therapies, Targeted Delivery Technologies, Regenerative Medicine, CRISPR |
| Website | ||
| Website | intractpharma.com | ligandal.com |
About Intract Pharma
Intract Pharma is a dynamic biotechnology company committed to advancing patient care by transforming traditional injectable therapies into oral formulations. Founded in 2016 and headquartered in the United Kingdom, the company is pioneering innovations in the oral delivery of complex proteins, part...
About Ligandal
Ligandal is a biotechnology startup founded in 2014 and based in the United States. The company's slogan, "Ligandal is developing precision molecular therapeutics and targeted delivery technologies." reflects its core focus on genetic medicine and nanotechnology to develop personalized therapies. Li...
We will tell you when either one moves
BounceWatch watches Intract Pharma and Ligandal for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Intract Pharma and Ligandal — by email.
Frequently Asked Questions
Compare Intract Pharma with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Intract Pharma on 2 Jun 2026, and Ligandal on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.